Related Experiment Video
Updated: Jul 12, 2025
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
716
Assessing potential of psilocybin for depressive disorders
Zofia Kozak1, Matthew W Johnson2, Scott T Aaronson1,3
1Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Expert Opinion on Investigational Drugs
|October 23, 2023
Summary
Psilocybin shows promise for treating depression, with clinical trials demonstrating its efficacy. Patients with treatment-resistant depression may be the most suitable candidates for this novel therapy.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Growing interest in psilocybin for treating depressive disorders.
- Clinical trials indicate psilocybin's effectiveness in reducing depression symptoms.
Purpose of the Study:
- To review the current understanding of psilocybin's therapeutic mechanisms.
- To examine clinical data on psilocybin for depression treatment.
Main Methods:
- Literature review of clinical trials and mechanistic studies.
- Analysis of existing data on psilocybin's efficacy and safety.
Main Results:
- Psilocybin demonstrates efficacy in reducing depressive symptoms.
- Further research is needed to fully understand risks and optimize treatment.
Conclusions:
- Psilocybin is a potential novel therapeutic agent for depression.
- Patients with treatment-resistant depression may benefit most from psilocybin therapy currently.
Related Concept Videos
01:27Hallucinogens and Psychedelics
182
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
182
01:23Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
01:27Depressive Disorders: Etiology
104
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
104
01:22CNS Stimulants: Psychedelic Agents
160
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
160
01:27Depressive Disorders: MDD and Dysthymia
138
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
138
01:18Depression: Overview
256
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
256